RecruitingNCT03193541

A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer


Sponsor

Cedars-Sinai Medical Center

Enrollment

900 participants

Start Date

Dec 30, 2016

Study Type

OBSERVATIONAL

Conditions

Summary

To improve upon the non-invasive detection of BCa by further validating a multiplex ELISA assay directed at a BCa-associated diagnostic signature in voided urine samples of patients with microscopic hematuria.


Eligibility

Min Age: 18 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This study is evaluating a new urine-based blood marker test to determine whether it can accurately identify bladder cancer in people who have blood in their urine (a condition called microscopic haematuria — blood not visible to the eye, only detectable under a microscope or by lab test). **You may be eligible if...** - You are 18 years or older - You have had blood detected in your urine within the past 3 months (confirmed by lab test) - You are willing to give informed consent **You may NOT be eligible if...** - You have a prior history of bladder cancer - You have had any other cancer (except non-melanoma skin cancer) - You have an active urinary tract infection or urinary obstruction - You have active kidney stones - You have kidney insufficiency (poor kidney function) - You have had recent urological procedures Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(8)

VA Long Beach Healthcare System

Long Beach, California, United States

Cedars-Sinai Medical Center

Los Angeles, California, United States

UCLA Medical Center

Los Angeles, California, United States

Hoag Memorial Hospital Presbyterian

Newport Beach, California, United States

University of Rochester Medical Center

Rochester, New York, United States

UT Southwestern Medical Center at Dallas

Dallas, Texas, United States

Nara Prefecture Seiwa Medical Center

Nara, Nara, Japan

Nara Medical University

Nara, Japan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03193541


Related Trials